炔诺酮肟(NETO)与炔诺酮(NET)在猴体内的药代动力学  

PHARMACOKINETICS OF NORETHINDRONE-3-OXIME AND NORETHINDRONE IN RHESUS MONKEYS

作　　者：傅官铭[1] 左明达[1] 李敦周 周美英[2] 赵夏令[2] 王国平[2] 魏振年 王训立[3] 李志雄[3] 

机构地区：[1]同济医科大学计划生育研究所,武汉430030 [2]中国科学院上海原子核研究所,上海201800 [3]福建省计划生育科学研究所,福州350001

出　　处：《药学学报》1991年第1期1-5,共5页Acta Pharmaceutica Sinica

基　　金：世界卫生组织资助

摘　　要：利用HPLC分离和液闪测定放射性的方法,研究了恒河猴ⅳ和鼻饲NETO和NET的药代动力学。鼻饲后NETO和NET吸收迅速,24 h内均基本消除。鼻饲或ⅳNETO后,一部分迅速转变为NET,一部分以原药形式存在。两药的血药浓度—时间曲线符合po或ⅳ的二室开放模型。二原药的主要药代动力学参数无显著差异。NETO与NET的鼻饲绝对生物利用度分別为64.46±34.60与35.02±26.49%。After intravenous administration or nasal feeding of(6, 7-~3H.)-labelled norethindrone-3-oxime(NETO) or norethindrone (NET) to rhesus monkeys, the serum concentrations were determined by measuring the radioactivity after separation with HPLC. The serum concentrations of total extractable radioactivity were also measured without HPLC separation. In cases of nasal feeding, NETO and NET were quickly absorbed, and almost all of them were eliminated within 24 hours. NETO, when given via both routes, was partly metabolized to NET and partly remained in original form. The blood concentration-time curves for NETO and NET were adequately fitted to two compartment models. No significant difference in pharmacokinetic parameters between the two drugs was observed. The absolute bioavailability for NETO and NET were found to be 64.46±34.60% and 35.02+26.49% respectively.

关 键 词：炔诺酮肟 炔诺酮 药代动力学 猴 

分 类 号：R969.1[医药卫生—药理学]